Most patients using GLP-1 medications like semaglutide or tirzepatide can expect: 510% weight loss in the first 3 months 1020% total body weight loss over time Reduced appetite and cravings within the first few weeks Results vary based on: Starting weight Metabolism and insulin resistance Consistency with treatment Our goal is steady, sustainable progressnot rapid rebound weight loss What to Expect Week 14: Appetite reduction, fewer cravings Month 23: Noticeable weight loss and improved control over eating Month 3+: Continued fat loss and metabolic improvements We adjust dosing and treatment based on your response to maximize results and minimize side effects Simple, Transparent Pricing Medication Cost Compounded GLP-1 medications (cash pay): Semaglutide $80$140 / month Tirzepatide $150$375 / month Brand-name medications: Wegovy, Ozempic, Zepbound, Mounjaro Why Choose Be Well Medical Group for Weight Loss We provide medical, personalized weight loss carenot one-size-fits-all programs or med spa shortcuts
Compared to effector T cells, regulatory T cells (Tregs) exhibit a greater preference for lipid metabolism and demonstrate resistance to ferroptosis, whereas effector T cells rely on glutamine metabolism, rendering them more susceptible to ferroptosis (122)
NAD+ and mitochondrial biogenesis NAD+ works as a vital cofactor that changes metabolism, activates sirtuins, and keeps mitochondrial fitness through mechanisms like the mitochondrial unfolded protein response
The Bottom Line GLP-1 medications are important treatments for many patients, but newer research has raised questions about a possible association between semaglutide and NAION
Research also shows: Slower worsening of kidney disease in people with diabetes Improvement in certain fatty liver conditions Improvement in sleep apnea symptoms related to obesity This growing evidence explains why insurance coverage is expanding
